Regencell Bioscience Holdings Ltd SEC filings RGC

Regencell Bioscience Holdings Ltd has 85 filings in SEC EDGAR's recent list, going back to Nov 13, 2020. Its latest annual report, Form 20-F, was filed on Oct 7, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on May 22, 2026.

Regencell Bioscience Holdings Ltd SEC filings
Form Description Filed Period
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 11, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 13, 2025 —
SC 13D/A Amended ownership over 5% (active) Jul 26, 2022 —
SC 13D/A Amended ownership over 5% (active) May 16, 2022 —
SC 13D/A Amended ownership over 5% (active) Apr 4, 2022 —
SC 13D/A Amended ownership over 5% (active) Dec 30, 2021 —
SC 13G Ownership over 5% (passive) Dec 15, 2021 —
SC 13D/A Amended ownership over 5% (active) Nov 22, 2021 —
SC 13D Ownership over 5% (active) Jul 27, 2021 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
RGC (Nasdaq)
Incorporated in
Cayman Islands
Headquarters
Hong Kong
SEC filer status
Large accelerated filer
SEC CIK
1829667

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.